Delivering Advanced Therapeutics - Critical Pharmaceuticals

Advanced Drug Delivery Technology Platform Critical Pharmaceutical's breakthrough technologies enable nasal and long acting injectable delivery of biologic and challenging small molecule drugs.
Biobetter Product Pipeline Critical Pharmaceuticals has a pipeline of unique biological drug products utilising it's proprietary drug delivery technologies.
Improve Therapeutic Outcome Critical Pharmaceuticals products and technology improve patient convenience and therapeutic outcomes.

CP024 has completed two Phase 1 clinical trials where our intranasal growth hormone has shown comparable activity to injection.

CriticalSorb enables the non-invasive nasal delivery delivery of high-value biologic products and challenging small molecule drugs.

CriticalMix enables the manufacture of highly active sustained release depot products for bimonthly, monthly or less frequent injection.

12th February 2013: Successful Completion of Second Clinical Trial on CP024 Intranasal Growth Hormone